First ever FDA cleared, clinically validated blood test to help physicians assess a woman’s menopausal status. By measuring ultra-low levels of Anti-Müllerian Hormone (AMH), the test provides estimates of the time to final menstrual period, thus facilitating better preventive care for symptoms that disrupt everyday quality of life and to reduce the risk of diseases and conditions associated with loss of ovarian hormones.
